Purdue Pharma, U.S. states agree to new opioid settlement

The plan could be worth more than $10 billion over time and calls for members of the Sackler family to give up control of the company so it can be turned into a new entity with profits used to fight the opioid crisis.

Gov. Mills barely mentioned opioid crisis in State of the State, and people noticed

Although the governor's speech drew some criticism, administration officials say they're focused on the epidemic of fatal overdoses and making systemic changes to improve services and save lives.

Native American tribes reach landmark opioid settlement

All federally recognized tribes will be able to participate in the settlements, even if they did not sue over opioids.

Jury holds CVS, Walgreens, Walmart responsible for role in Ohio opioid crisis

This was the first time pharmacy companies had completed a trial to defend themselves in a drug crisis that has killed a half-million Americans over the past 2 decades.

Federal agents charge 13 people in New England drug trafficking pipeline

The crackdown targeted a Massachusetts-based gang that moved drugs and counterfeit pills into Maine and New Hampshire.

Area health clinics to develop low barrier opioid use disorder treatment program

Health clinics from around the state are participating in a 12-month pilot program to develop and maintain low barrier opioid use disorder treatment programs.

Judge conditionally approves Purdue Pharma opioid settlement

Under the settlement, the Sackler family will give up ownership of the company and contribute $4.5 billion. But the Sacklers will be shielded from any future lawsuits over opioids.

Lead with love: Outliving opioids

30 Maine school districts join suit against opioid manufacturer Purdue Pharma

At least 30 Maine school districts have joined a class-action lawsuit against opioid manufacturer Purdue Pharma for damages related to the opioid crisis.

First opioid jury trial marks high-stakes test for drug industry

Analysts predict companies eventually will have to spend tens of billions of dollars combined to resolve thousands of lawsuits over their role in the U.S. opioid epidemic.